Who is sponsoring OCTOPUS?

OCTOPUS is sponsored by University of Colorado, Denver.

What drugs are being tested in OCTOPUS?

Interventions: Ranibizumab, Ranibizumab and MMC, MMC.

What is the status of OCTOPUS?

OCTOPUS is currently COMPLETED.

Last reviewed 2016-08-19 · How we verify

Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS Study)

NCT00661583 Phase 1/Phase 2 COMPLETED Results posted

The purpose of the study is to study the safety of the combination of ranibizumab and MMC vs monotherapy MMC vs intravitreal ranibizumab injection in patients with glaucoma.

Details

Lead sponsor	University of Colorado, Denver
Phase	Phase 1/Phase 2
Status	COMPLETED
Enrolment	30
Start date	2008-04
Completion	2014-09

Conditions

Glaucoma

Interventions

Ranibizumab
Ranibizumab and MMC
MMC

Primary outcomes

Assessment of Ocular Adverse Events — 6 months
To assess ocular adverse events of combination ranibizumab and MMC therapy at 6 months

Countries

United States